Scott Runyon

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Aplnr knockout mice display sex-specific changes in conditioned fear

Therapeutic and prophylactic vaccines to counteract fentanyl use disorders and toxicity

Synthesis of [H-3] and [C-14]genipin

Identification of potent pyrazole based APELIN receptor (APJ) agonists

Functionalized 6-(piperidin-1-yl)-8,9-diphenyl purines as inverse agonists of the CB1 receptor - SAR efforts towards selectivity and peripheralization

Apelin receptor (APJ) agonists and uses thereof

Functionalized 6-(piperidin-1-yl)-8,9-diphenyl purines as peripherally restricted inverse agonists of the CB1 receptor

Formulation and characterization of conjugate vaccines to reduce opioid use disorders suitable for pharmaceutical manufacturing and clinical evaluation

Preclinical efficacy and characterization of candidate vaccines for treatment of opioid use disorders using clinically viable carrier proteins

Apelin receptor (APJ) agonists and uses thereof

Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties

Potent and selective tetrahydroisoquinoline kappa opioid receptor antagonists of lead compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)

Potent and selective tetrahydroisoquinoline kappa opioid receptor antagonists of lead compound (3r)-7-hydroxy-n-[(1s)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (pdtic)

Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists

Anti-Mullerian hormone as a biomarker for acute testicular degeneration caused by toxic insults to stallion testes

Development of a peripherally restricted aryl urea based cb1 receptor antagonist for alcoholic steatosis

Blocking alcoholic steatosis in mice with a peripherally restricted purine antagonist of the type 1 cannabinoid receptor

Opioid dose- and route-dependent efficacy of oxycodone and heroin vaccines in rats

Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse

Discovery of novel proline-based neuropeptide FF receptor antagonists